Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

被引：80

作者：

Fujisawa, Keiko ^{[1
]}

Katakami, Naoto ^{[1
,2
]}

Kaneto, Hideaki ^{[1
]}

Naka, Toyoko ^{[1
]}

Takahara, Mitsuyoshi ^{[1
]}

Sakamoto, Fumie ^{[1
]}

Irie, Yoko ^{[1
]}

Miyashita, Kazuyuki ^{[1
]}

Kubo, Fumiyo ^{[1
]}

Yasuda, Tetsuyuki ^{[1
]}

Matsuoka, Taka-aki ^{[1
]}

Shimomura, Iichiro ^{[1
]}

机构：

[1] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka 5650871, Japan

[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Suita, Osaka 5650871, Japan

来源：

ATHEROSCLEROSIS | 2013年 / 227卷 / 02期

关键词：

sRAGE; RAGE; Cardiovascular event; Atherosclerosis; Type; 2; diabetes; GLYCATION END-PRODUCTS; CORONARY-ARTERY-DISEASE; ENDPRODUCTS RAGE; RECEPTOR; ATHEROSCLEROSIS; ASSOCIATION; SRAGE; FORM;

D O I：

10.1016/j.atherosclerosis.2013.01.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is still controversial whether circulating soluble form of receptor for AGE (sRAGE) is associated with atherosclerosis in diabetic patients. In this study, we enrolled 276 Japanese type 2 diabetic subjects without history of cardiovascular disease (CVD), assessed their baseline clinical and biochemical data including serum sRAGE levels, and prospectively evaluated the association between these parameters and CVD events. The median follow-up period was 5.6 years and there were 25 new CVD events. The tertile analysis showed that the risk for CVD events was higher as serum sRAGE levels were increased (p for trend = 0.046). A multivariate Cox proportional hazards regression analysis revealed that serum sRAGE levels were independently associated with CVD (HR per 1SD = 1.59, 95% CI 1.04-2.45, p = 0.034), even after adjusting for conventional coronary risk factors. In summary, elevated sRAGE levels were associated with the increased risk of CVD in Japanese type 2 diabetic subjects. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

页码：425 / 428

页数：4

共 14 条

[1] Inverse Association between Circulating Levels of Soluble Receptor for Advanced Glycation End-Products and Coronary Plaque Burden [J].

Basta, Giuseppina ;

Del Turco, Serena ;

Navarra, Teresa ;

Mazzarisi, Alessandro ;

Cocci, Franca ;

Coceani, Michele ;

Bianchi, Massimiliano ;

Schlueter, Mathis ;

Marraccini, Paolo .

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (10) :941-948

[2] RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].

Bucciarelli, LG ;

Wendt, T ;

Qu, W ;

Lu, Y ;

Lalla, E ;

Rong, LL ;

Goova, MT ;

Moser, B ;

Kislinger, T ;

Lee, DC ;

Kashyap, Y ;

Stern, DM ;

Schmidt, AM .

CIRCULATION, 2002, 106 (22) :2827-2835

[3] Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury [J].

Cai, Xue Ying ;

Lu, Lin ;

Wang, Ya Nan ;

Jin, Cao ;

Zhang, Rui Yan ;

Zhang, Qi ;

Chen, Qiu Jing ;

Shen, Wei Feng .

ATHEROSCLEROSIS, 2011, 217 (02) :536-542

[4] Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes An Analysis From the CARDS Trial [J].

Colhoun, Helen M. ;

Betteridge, D. John ;

Durrington, Paul ;

Hitman, Graham ;

Neil, Andrew ;

Livingstone, Shona ;

Charlton-Menys, Valentine ;

Bao, Weihang ;

DeMicco, David A. ;

Preston, Gregory M. ;

Deshmukh, Harshal ;

Tan, Kathryn ;

Fuller, John H. .

DIABETES, 2011, 60 (09) :2379-2385

[5] Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men [J].

Falcone, C ;

Emanuele, E ;

D'Angelo, A ;

Buzzi, MP ;

Belvito, C ;

Cuccia, M ;

Geroldi, D .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1032-1037

[6] Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS) [J].

Hudson, Barry I. ;

Moon, Yeseon Park ;

Kalea, Anastasia Z. ;

Khatri, Minesh ;

Marquez, Chensy ;

Schmidt, Ann Marie ;

Paik, Myunghee C. ;

Yoshita, Mitsuhiro ;

Sacco, Ralph L. ;

DeCarli, Charles ;

Wright, Clinton B. ;

Elkind, Mitchell S. V. .

ATHEROSCLEROSIS, 2011, 216 (01) :192-198

[7] Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis Observations from the Dallas Heart Study [J].

Lindsey, Jason B. ;

de Lemos, James A. ;

Cipollone, Francesco ;

Ayers, Colby R. ;

Rohatgi, Anand ;

Morrow, David A. ;

Khera, Amit ;

McGuire, Darren K. .

DIABETES CARE, 2009, 32 (07) :1218-1220

[8] Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention [J].

McNair, Erick D. ;

Wells, Calvin R. ;

Qureshi, Mabood ;

Basran, Rashpal ;

Pearce, Colin ;

Orvold, Jason ;

Devilliers, Jacobus ;

Prasad, Kailash .

CLINICAL CARDIOLOGY, 2010, 33 (11) :678-685

[9] Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease [J].

Nakamura, Kazuo ;

Yamagishi, Sho-ichi ;

Adachi, Hisashi ;

Kurita-Nakamura, Yayoi ;

Matsui, Takanori ;

Yoshida, Takafumi ;

Sato, Akira ;

Imaizumi, Tsutomu .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (05) :368-371

[10] Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-Year Follow-Up Study [J].

Nin, Johanna W. M. ;

Jorsal, Anders ;

Ferreira, Isabel ;

Schalkwijk, Casper G. ;

Prins, Martin H. ;

Parving, Hans-Henrik ;

Tarnow, Lise ;

Rossing, Peter ;

Stehouwer, Coen D. A. .

DIABETES, 2010, 59 (08) :2027-2032

← 1 2 →